Chikungunya Virus Inhibitor Study based on Molecular Docking Experiments

被引：0

作者：

Saraiva, A. A. ^{[2
,6
]}

Jeferson, Soares ^{[1
]}

Miranda, Castro ^{[1
]}

Moura Sousa, Jose Vigno ^{[1
]}

Fonseca Ferreira, N. M. ^{[3
,4
]}

Batista Neto, J. E. S. ^{[6
]}

Soares, Salviano ^{[3
]}

Valente, Antonio ^{[2
,5
]}

机构：

[1] UESPI Univ State Piaui, Piripiri, Brazil

[2] Univ Tras Os Montes & Alto Douro, Vila Real, Portugal

[3] Coimbra Polytech ISEC, Coimbra, Portugal

[4] Polytech Inst Porto, Inst Engn, Knowledge Engn & Decis Support Res Ctr GECAD, Porto, Portugal

[5] INESC TEC Technol & Sci, Porto, Portugal

[6] Univ Sao Paulo, Sao Carlos, Brazil

来源：

PROCEEDINGS OF THE 13TH INTERNATIONAL JOINT CONFERENCE ON BIOMEDICAL ENGINEERING SYSTEMS AND TECHNOLOGIES, VOL 3: BIOINFORMATICS | 2020年

关键词：

Chikungunya; Molecular; Docking; REPLICATION;

D O I：

10.5220/0009118602000205

中图分类号：

R318 [生物医学工程];

学科分类号：

0831 ;

摘要：

Chikungunya virus disease transmitted by the sting of the mosquito 'Aedes aegypti' presenting an epidemic in some regions. In order to have an early diagnosis and the best treatment technique, it establishes the study of inhibitors for laboratory elaboration of a drug from molecular docking. As a result you have a better chance of using Suramin followed by Silibin.

引用

页码：200 / 205

页数：6

共 50 条

[31] Inhibitor based refinement of homology modeled protein structures for molecular docking
Antes, Iris
Lengauer, Thomas
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 232 : 403 - 403
[32] Molecular docking and ligand specificity in fragment-based inhibitor discovery
Yu Chen
Brian K Shoichet
Nature Chemical Biology, 2009, 5 : 358 - 364
[33] Molecular docking and QSAR study on imidazole derivatives as 14α-demethylase inhibitor
Davood, Asghar
Iman, Maryam
TURKISH JOURNAL OF CHEMISTRY, 2013, 37 (01) : 119 - 133
[34] Molecular docking and ligand specificity in fragment-based inhibitor discovery
Chen, Yu
Shoichet, Brian K.
NATURE CHEMICAL BIOLOGY, 2009, 5 (05) : 358 - 364
[35] Study of molecular docking of an HIV-1 protease inhibitor - Streptolydigin
Li Jin-Tao
Li Yan-Ni
Yuan Ying-Jin
ACTA CHIMICA SINICA, 2006, 64 (24) : 2491 - 2495
[36] Consensus scoring model for the molecular docking study of mTOR kinase inhibitor
Li, Dong-Dong
Meng, Xiang-Feng
Wang, Qiang
Yu, Pan
Zhao, Lin-Guo
Zhang, Zheng-Ping
Wang, Zhen-Zhong
Xiao, Wei
JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2018, 79 : 81 - 87
[37] Suramin is a potent inhibitor of Chikungunya and Ebola virus cell entry
Henss, Lisa
Beck, Simon
Weidner, Tatjana
Biedenkopf, Nadine
Sliva, Katja
Weber, Christopher
Becker, Stephan
Schnierle, Barbara S.
VIROLOGY JOURNAL, 2016, 13
[38] A study of the chikungunya virus in humans in Turkey
Atalay, Tugba
Kaygusuz, Sedat
Azkur, Ahmet Kursat
TURKISH JOURNAL OF MEDICAL SCIENCES, 2017, 47 (04) : 1161 - 1164
[39] Suramin is a potent inhibitor of Chikungunya and Ebola virus cell entry
Lisa Henß
Simon Beck
Tatjana Weidner
Nadine Biedenkopf
Katja Sliva
Christopher Weber
Stephan Becker
Barbara S. Schnierle
Virology Journal, 13
[40] A Novel Sphingosine Kinase Inhibitor Suppresses Chikungunya Virus Infection
Oyewole, Opeoluwa O.
Dunnavant, Kyle
Bhattarai, Shaurav
Kharel, Yugesh
Lynch, Kevin R.
Santos, Webster L.
Reid, St Patrick
VIRUSES-BASEL, 2022, 14 (06):

← 1 2 3 4 5 →